Immune responses of lambs to the fusion (F) glycoprotein of bovine respiratory syncytial virus expressed on insect cells infected with a recombinant baculovirus

Vaccine

Volumn 14, Issue 8, 1996, Pages 773-779

  Sharma, A K ^a   Woldehiwet, Z ^a   Walrevens, K ^b   Letteson, J ^b  

^a UNIVERSITY OF LIVERPOOL   (United Kingdom)

^b UNIVERSITY OF NAMUR   (Belgium)

Author keywords

Bovine respiratory syncytial virus; Cytotoxic and lympho proliferative response; Lambs; Recombinant F protein

Indexed keywords

HYBRID PROTEIN; RECOMBINANT PROTEIN; VIRUS VACCINE;

ANIMAL EXPERIMENT; ARTICLE; BACULOVIRUS; CATTLE; CONTROLLED STUDY; CYTOTOXICITY; GENE EXPRESSION; IMMUNE RESPONSE; IMMUNIZATION; LAMB; NONHUMAN; PRIORITY JOURNAL; PROVOCATION TEST; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; VIRUS RECOMBINANT;

EID: 0030175927     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/0264-410X(95)00248-Y     Document Type: Article

References (48)

1. 1 Van der Poel, W.H.M., Brand, A., Kramps, J.A. and Van Oirschot, J.T. Respiratory syncylial virus infections in human beings and in cattle. J. Infect. 1994, 29, 215
2. 2 Walsh, E.E., Hall, C.B., Briselli, M., Brandriss, M.W. and Schlesinger, J.J. Immunization with glycoprotein subunits of respiratory syncytial virusto protect cotton rats against viral infection. J. Infect. Dis. 1987, 155, 1198
3. 3 Routledge, E.G., Willcocks, M.M., Sampson, A.C.R. et al. The purification of four respiratory syncytial virus proteins and their evaluation as protective agents against experimental infection in BALB/c mice. J. Gen. Virol. 1988, 69, 293
4. 4 Pemberton, R.M., Cannon, M.J., Openshaw, P.J.M., Ball, L.A., Wertz, G.W. and Askona, B.A. Cytotoxic T cell specificity for respiratory syncytial virus proteins: fusion protein is an important target antigen J. Gen. Virol. 1987, 68, 2177
5. 5 Gupta, R., Yewdell, J.W., Olmsted, R.A., Collins, P.L. and Bennink, J.R. Primary pulmonary murine cytotoxic T lymphocyte specificity in respiratory syncytial virus pneumonia. Microbiol. Path. 1990, 9, 13
6. 6 Walravens, K., Kettman, R., Collard, A., Coppe, P. and Burny, A. Sequence comparison between the fusion protein of human and bovine respiratory syncytial viruses. J. Gen. Virol. 1990, 71, 3009
7. 7 Nelson, L.D., Kelling, C.L. and Anderson, G.A. Antibody response of calves to immunoaffinity-purified bovine respiratory syncytial virus VP70 after vaccination and challenge exposure. Am. J. Vet. Res. 1992, 53, 1315
8. 8 Wathen, M.W., Brideau, R.J. and Thomsen, D.R. Immunization of cotton rats with the human respiratory syncytial virus F glycoprotein produced using a baculovirus vector. J. Infect. Dis. 1989, 159, 265
9. 9 Wathen, M.W., Brideau, R.J., Thomsen, D.R. and Murphy, B.R. Characterization of a novel human respiratory syncytial virus chimeric FG glycoprotein expressed using a baculovirus vector. J. Gen. Virol. 1989, 70, 2625
10. 10 Brideau, R.J., Walters, R.R., Stier, M. and Wathen, M.W. Protection of cotton rats against human respiratory syncytial virus by vaccination with a novel chimeric FG glycoprotein. J. Gen. Virol. 1989, 70, 2637
11. 11 Wathen, M.W., Kakuk, T.J., Brideau, R.J., Hausknecht, E.C. et al. Vaccination of cotton rats with a chimeric FG glycoprotein of human respiratory syncytial virus induces minimal pulmonary pathology on challenge. J. Infect. Dis. 1991, 163, 477
12. 12 Connors, M., Collins, P.L., Fireston, C. et al. Cotton rats previously immunized with a chimeric RSV FG glycoprotein develop enhanced pulmonary pathology when infected with RSV, phenomenon not encountered following immunization with vaccinia-RSV recombinants or RSV. Vaccine 1992, 10, 475
13. 13 Sharma, R. and Woldehiwet, Z. Pathogenesis of bovine respiratory syncytial virus in lambs. Vet. Microbiol. 1990, 23, 267
14. 14 Lapin, C.D., Haitt, P.W., Langsten, C., Mason, E. and Piedra, P.T. A lamb model for human respiratory syncytial virus. Pediatr, Pulmonol. 1993, 15, 151-156
15. 15 O'Reilly, D.R., Miller, L.K. and Luckow, V.A. Baculovirus expression vectors: a laboratory manual. 1992. W. H. Freeman and Company, San Francisco, CA
16. 16 Matsuura, Y., Possee, R.D., Overton, H.A. and Bishop, D.H.L. Baculovirus expression vectors: the requirements for high level expression of proteins, including glycoproteins J. Gen. Virol. 1987, 68, 1233
17. 17 Sharma, A.K. Ph.D. Thesis, 1994, University of Liverpool, Liverpool, UK
18. 18 Woldehiwet, Z. and Hussin, A.A. Cytotoxic T cell responses in lambs experimentally infected with Border disease virus. Vet. Immunol. Immunopathol. 1994, 41, 201
19. 19 Hussin, A.A. and Woldehiwet, Z. Lymphocyte responses to viral antigen and phytohaemagglutinin in persistently viraemic sheep and lambs experimentally infected with border disease virus. Vet. Microbiol. 1994, 39, 89
20. 20 Taylor, G., Stott, E.J. and Thomas, L.H. Lymphocyte transformation responses of calves to respiratory syncytial virus. J. Med. Virol. 1987, 22, 333-344
21. 21 Murphy, B.R., Hall, S.L., Kulkarni, A.B., Crowe, J.E. et al. An update on approcaches to the development of respiratory syncytial virus (RSV) and parainfluenza virus type 3 (PIV3) vaccines. Virus Res. 1994, 32, 13
22. 22 Takahashi, H., Takeshita, T., Morein, B., Putney, S., Germain, R.N. and Berzofsky, J.A. Induction of CD8+ cytotoxic T cells by immunisation with purified HIV-1 envelope protein in ISCOMS. Nafure 1990, 344, 873
23. 23 Trudel, M., Nadon, F., Seguin, C., Brault, S., Lusignan, Y. and Lemieux, S. Initiation of cytotoxic T-cell responses and protection of Balb/c mice by vaccination with experimental ISCOMS respiratory syncytial vaccine. Vaccine 1992, 10, 107
24. 24 Murphy, B.R., Paradiso, P.R., Hildreth, S., Hockmeyer, W.T. et al. Immunisation of cotton rats with the fusion (F) and large (G) glycoproteins of respiratory syncytial virus (RSV) protects against RSV challenge without potentiating RSV disease. Vaccine 1989, 7, 533
25. 25 Taylor, G., Stott, E.J. and Hayle, A.J. Cytotoxic lymphocytes in lungs of mice infected with respiratory syncytial virus. J. Gen. Virol. 1985, 66, 2533-2538
26. 26 Sharma, A.K. and Woldehiwet, Z. Cellular immune responses of lambs to challenge with bovine respiratory syncytial virus. Clin. Exp. Immunol. 1995, 101, 288-294
27. 27 Gatei, M.H., Naif, H.M., Kumar, S., Boyle, D.B. et al. Protection of sheep against bovine leukemia virus (BLV) infection by vaccination with recombinant vaccinia viruses expressing BLV envelope glycoproteins: correlation of protection with CD4 T-cell response to gp51 peptide 51-70. J. Virol. 1993, 67, 1803
28. 28 Chiba, Y., Higashidate, Y., Suga, K., Honjo, K., Tsutsumi, H. and Ogra, P.L. Development of cell-mediated cytotoxic immunity to respiratory syncytial virus in human infants following naturally acquired infection. J. Med. Virol. 1989, 28, 133
29. 29 Cherrie, A.H., Anderson, K., Wertz, G.W. and Openshaw, P.J.M. Human cytotoxic T cells stimulated by antigen on dendritic cells recognize the N, SH, F, M, 22K, and 1b proteins of the respiratory syncytial virus. J. Virol. 1992, 66, 2202
30. 30 Issacs, D., MacDonlad, N.E., Bangham, C.R.M. and McMichael, AJ. The specific cytotoxic T cell response of adult volunteers to infection with respiratory syncytial virus. Immunol. Infect. Dis. 1990, 1, 5
31. 31 Bangham, C.R.M., Openshaw, P.J.M., Ball, L.A., King, A.M.Q., Wertz, G.W. and Askonas, B.A. Human and murine cytotoxic T cells specific to respiratory syncytial virus recognize the viral nucleoprotein (N), but not the major glycoprotein (G), expressed by the vaccinia virus recombinants. J. Immunol. 1986, 137, 3973
32. 32 Nicholas, J.A., Rubino, K.L., Leveley, M.E., Adams, E.G. and Collins, P.L. Cytotoxic T lymphocyte responses to respiratory syncytial virus: effector cell phenotype and target proteins. J. Virol. 1990, 64, 4232
33. 33 Openshaw, P.J.M., Anderson, K., Wertz, G.W. and Askonas, B.A. The 22 Kilodalton protein of respiratory syncytial virus is a major target for Kd-restricted cytototoxic T lymphocytes from mice primed by infection. J. Virol. 1990, 64, 1683
34. 34 Levine, S., Klaiber-Franco, R. and Paradiso, P.R. Demonstration that glycoprtein G is attachment protein of respiratory syncytial virus. J. Gen. Virol. 1987, 68, 2521
35. 35 Walsh, E.E. and Hruska, J. Monoclonal antibodies to respiratory syncytial virus proteins: identification of the fusion protein. J. Virol. 1983, 47, 171
36. 36 Elango, N., Satake, M. and Venkatesan, S. mRNA sequence of three respiratory syncytial virus genes encoding two nonstructural proteins and a 22K structural protein. J. Virol. 1986, 55, 101
37. 37 Johnson, P.R.Jr, Olmsted, R.A., Prince, G.A., Murphy, B.R. et al. Antigenic relatedness between glycoproteins of human respiratory syncytial virus subgroups A and B: evaluation of the contributions of F and G glycoproteins to immunity. J. Virol. 1987, 61, 3163
38. 38 Nicholas, J.A., Rubino, K.L., Leveley, M.E., Meyer, A.L. and Collins, P.L. Cytotoxic T cell activity against the 22-kDa protein of human respiratory syncytial virus (RSV) is associated with a significant reduction in pulmonary RSV replication. Virology 1991, 182, 664
39. 39 Olmsted, R.A., Elango, N., Prince, G.A., Murphy, B.R. et al. Expression of the F glycoprotein of respiratory syncytial virus by a recombinant vaccinia virus: comparison of the individual contributions of the F and G glycoproteins to host immunity. Proc. Natl Acad. Sci. USA 1986, 83, 7462
40. 40 Belshe, R.B., Anderson, E. and Walsh, E.E. Immunogenecity of purified F glycoprotein of respiratory syncytial virus: clinical and immune responses to subsequent natural infection in children. J. Infect. Dis. 1993, 168, 1024
41. 41 Olmsted, R.A., Buller, R.M.L., Collins, P.L. et al. Evaluation in non-human primates of the safety, immunogenicity and efficacy of recombinant vaccinia viruses expressing the F or G glycoprotein of respiratory syncytial virus. Vaccine 1988, 6, 519-524
42. 42 Anderson, J.J., Norden, J., Saunders, D., Toms, G.L. and Scott, R. Analysis of the local and systemic immune responses induced in Balb/c mice by experimental respiratory syncytial virus infection. J. Gen. Virol. 1990, 71, 1561
43. 43 Scott, R., Kaul, A., Scott, M., Chiba, Y. and Ogra, P.L. Development of in vitro correlates of cell-mediated immunity to respiratory syncytial virus infection in humans. J. Infect. Dis. 1978, 137, 810
44. 44 Welliver, R.C., Kaul, T.N. and Ogra, P.L. Cell-mediated immune response to respiratory syncytial virus infection: relationship to the development of reactive airway disease. J. Pediatr. 1984, 94, 370
45. 45 Fernand, G.W., Almond, J.R. and Henderson, F.W. Cellular and humoral immunity in recurrent respiratory syncytial virus infections. Pediat. Res. 1983, 17, 753
46. 46 Ellis, J.A., Belden, E.L., Haven, T.R. and Cavender, J. Bovine respiratory syncytial virus-specific immune responses in cattle following immunization with modified-live and inactivated vaccines. Analysis of proliferation and secretion of lymphokines by leukocytes in vitro. Vet. Immunol. Immunopath. 1992, 34, 21
47. 47 Anderson, J.J., Harrop, J.A., Peers, H., Turnbill, T., Toms, G.L. and Scott, R. Recognition of respiratory syncytial (RS) virus proteins by human and BALB/c CD4+ lymphocytes. J. Med. Virol. 1991, 35, 165
48. 48 Levely, M.A., Bannow, C.A., Smith, C.W. and Nicholas, J.A. Immunodominant T-cell epitope on the F protein of the respiratory syncytial virus recognized by human lymphocytes. J. Virol. 1991, 65, 3789